Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Combining effects of polymorphism of tumor necrosis factor alpha 5'-flanking region and HLA-DRB1 on radiological progression in patients with rheumatoid arthritis.

Ichikawa N, Kotake S, Hakoda M, Higami K, Kawasaki A, Furuya T, Nanke Y, Tsuchiya N, Tokunaga K, Kamatani N.

Mod Rheumatol. 2009;19(2):134-9. doi: 10.1007/s10165-008-0134-0. Epub 2008 Nov 12.

PMID:
19002558
2.

Combining effects of polymorphism of tumor necrosis factor α 5'-flanking region and HLA-DRB1 on radiological progression in patients with rheumatoid arthritis.

Ichikawa N, Kotake S, Hakoda M, Higami K, Kawasaki A, Furuya T, Nanke Y, Tsuchiya N, Tokunaga K, Kamatani N.

Mod Rheumatol. 2009 Apr;19(2):134-139. doi: 10.3109/s10165-008-0134-0.

PMID:
28925311
3.

Allele typing of human TNFA 5'-flanking region using polymerase chain reaction-preferential homoduplex formation assay (PCR-PHFA): linkage disequilibrium with HLA class I and class II genes in Japanese.

Matsushita M, Tsuchiya N, Nakayama T, Ohashi J, Shibue T, Shiota M, Oka T, Yamane A, Tokunaga K.

Tissue Antigens. 1999 Nov;54(5):478-84.

PMID:
10599887
4.

Tumor necrosis factor alpha 5'-flanking region, tumor necrosis factor receptor II, and HLA-DRB1 polymorphisms in Japanese patients with rheumatoid arthritis.

Shibue T, Tsuchiya N, Komata T, Matsushita M, Shiota M, Ohashi J, Wakui M, Matsuta K, Tokunaga K.

Arthritis Rheum. 2000 Apr;43(4):753-7. Erratum in: Arthritis Rheum. 2005 May;52(5):1619.

5.

The value of HLA-DRB1 shared epitope, -308 tumor necrosis factor-alpha gene promoter polymorphism, rheumatoid factor, anti-citrullinated peptide antibodies, and early erosions for predicting radiological outcome in recent-onset rheumatoid arthritis.

Reneses S, González-Escribano MF, Fernández-Suárez A, Pestana L, Davila B, Wichmann I, García A.

J Rheumatol. 2009 Jun;36(6):1143-9. doi: 10.3899/jrheum.081075. Epub 2009 May 1.

PMID:
19411391
6.

Association of tumor necrosis factor alpha polymorphism, but not the shared epitope, with increased radiographic progression in a seropositive rheumatoid arthritis inception cohort.

Khanna D, Wu H, Park G, Gersuk V, Gold RH, Nepom GT, Wong WK, Sharp JT, Reed EF, Paulus HE, Tsao BP; Western Consortium of Practicing Rheumatologists.

Arthritis Rheum. 2006 Apr;54(4):1105-16.

7.

Stromelysin 1 (matrix metalloproteinase 3) and HLA-DRB1 gene polymorphisms: Association with severity and progression of rheumatoid arthritis in a prospective study.

Constantin A, Lauwers-Cancès V, Navaux F, Abbal M, van Meerwijk J, Mazières B, Cambon-Thomsen A, Cantagrel A.

Arthritis Rheum. 2002 Jul;46(7):1754-62.

8.

Associations between HLA-DRB1, RANK, RANKL, OPG, and IL-17 genotypes and disease severity phenotypes in Japanese patients with early rheumatoid arthritis.

Furuya T, Hakoda M, Ichikawa N, Higami K, Nanke Y, Yago T, Kamatani N, Kotake S.

Clin Rheumatol. 2007 Dec;26(12):2137-41. Epub 2007 Sep 18.

PMID:
17876645
9.

Collagenase-1 (MMP-1) and HLA-DRB1 gene polymorphisms in rheumatoid arthritis: a prospective longitudinal study.

Constantin A, Lauwers-Cancès V, Navaux F, Abbal M, van Meerwijk J, Mazières B, Cambon-Thomsen A, Cantagrel A.

J Rheumatol. 2002 Jan;29(1):15-20.

PMID:
11824952
10.

Lack of association of HLA-DRB1 genotype with radiologic progression in Japanese patients with early rheumatoid arthritis.

Higami K, Hakoda M, Matsuda Y, Ueda H, Kashiwazaki S.

Arthritis Rheum. 1997 Dec;40(12):2241-7.

PMID:
9416863
11.

Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis.

van Gaalen FA, van Aken J, Huizinga TW, Schreuder GM, Breedveld FC, Zanelli E, van Venrooij WJ, Verweij CL, Toes RE, de Vries RR.

Arthritis Rheum. 2004 Jul;50(7):2113-21.

12.
13.
14.

Contribution of an adenine to guanine single nucleotide polymorphism of the matrix metalloproteinase-13 (MMP-13) -77 promoter region to the production of anticyclic citrullinated peptide antibodies in patients with HLA-DRB1*shared epitope-negative rheumatoid arthritis.

Iwamoto N, Kawakami A, Arima K, Tamai M, Nakamura H, Kawashiri SY, Kita J, Okada A, Koga T, Kamachi M, Yamasaki S, Ichinose K, Ida H, Origuchi T, Eguchi K.

Mod Rheumatol. 2011 Jun;21(3):240-3. doi: 10.1007/s10165-010-0375-6. Epub 2010 Nov 26.

PMID:
21107991
15.

Independent contribution of HLA-DRB1 and TNF alpha promoter polymorphisms to the susceptibility to Crohn's disease.

Kawasaki A, Tsuchiya N, Hagiwara K, Takazoe M, Tokunaga K.

Genes Immun. 2000 Aug;1(6):351-7.

16.

The influence of HLA-DRB1 alleles encoding the DERAA amino acid motif on radiological outcome in rheumatoid arthritis.

Mattey DL, Hassell AB, Plant MJ, Cheung NT, Dawes PT, Jones PW, Thomson W, Poulton KV, Hajeer AH, Ollier WE.

Rheumatology (Oxford). 1999 Dec;38(12):1221-7.

PMID:
10587549
17.

Independent association of rheumatoid factor and the HLA-DRB1 shared epitope with radiographic outcome in rheumatoid arthritis.

Mattey DL, Hassell AB, Dawes PT, Cheung NT, Poulton KV, Thomson W, Hajeer AH, Ollier WE.

Arthritis Rheum. 2001 Jul;44(7):1529-33.

18.

Interaction between RANKL and HLA-DRB1 genotypes may contribute to younger age at onset of seropositive rheumatoid arthritis in an inception cohort.

Wu H, Khanna D, Park G, Gersuk V, Nepom GT, Wong WK, Paulus HE, Tsao BP.

Arthritis Rheum. 2004 Oct;50(10):3093-103.

19.
20.

Characterization of cumulative joint damage patterns in patients with rheumatoid arthritis: a clinical, serological, and gene polymorphism perspective.

Alarcon RT, Fernandes Ada R, Laurindo IM, Bértolo MB, Pinheiro GC, Andrade LE.

J Rheumatol. 2015 Mar;42(3):405-12. doi: 10.3899/jrheum.131177. Epub 2015 Feb 1.

PMID:
25641888

Supplemental Content

Support Center